Showing results (111-120 of 288) with videos related to

Sort By:
Pageof 29
Journal of Asthma and Allergy|December 19, 2019
Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe AsthmaJ Mark FitzGerald, Eugene R Bleecker, Arnaud Bourdin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 25, 2022
Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma ManagementWilliam W Busse, Carl B Abbott, Guillaume Germain, et al.
The New England Journal of Medicine|June 28, 2018
Combined Analysis of Asthma Safety Trials of Long-Acting β2-AgonistsWilliam W Busse, Eric D Bateman, Arthur L Caplan, et al.
The Journal of Allergy and Clinical Immunology|April 26, 2024
Alzheimer incidence and prevalence with and without asthma: A Medicare cohort studyChristie M Bartels, Yi Chen, W Ryan Powell, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2004
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL studyEric D Bateman, Homer A Boushey, Jean Bousquet, et al.
Lancet (London, England)|December 4, 2016
Should recommendations about starting inhaled corticosteroid treatment for mild asthma be based on symptom frequency: a post-hoc efficacy analysis of the START studyHelen K Reddel, William W Busse, Søren Pedersen, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2008
Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trialWilliam W Busse, Elliot Israel, Harold S Nelson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 25, 2019
Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthmaWilliam W Busse, Marc Humbert, Tmirah Haselkorn, et al.
Thorax|August 11, 2011
Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trialWilliam W Busse, Eugene R Bleecker, Eric D Bateman, et al.
Respiratory Research|December 23, 2011
Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthmaAshley Woodcock, Eugene R Bleecker, William W Busse, et al.
Pageof 29